Literature DB >> 8143016

Lidocaine as a diluent for ceftriaxone in the treatment of gonorrhea. Does it reduce the pain of the injection?

A Schichor1, B Bernstein, H Weinerman, J Fitzgerald, E Yordan, N Schechter.   

Abstract

OBJECTIVE: To compare the pain associated with ceftriaxone sodium injections by using two different diluents, ie, lidocaine hydrochloride and sterile water.
DESIGN: Prospective study of adolescents who were culture positive for gonorrhea. Random selection of the diluent used for the intramuscular ceftriaxone therapy.
SETTING: Urban, hospital-based adolescent medicine service.
SUBJECTS: Thirty-nine adolescents and young adults, predominantly of black or Hispanic backgrounds, ranging in age between 14 and 23 years (mean age, 17.6 years; median age, 17 years), of whom 27 were females.
METHODS: Pain predictions were elicited from the adolescents before treatment. Pain ratings were obtained at five time intervals after the injections. All ratings were obtained by using a visual analog scale.
RESULTS: No pain prediction differences before the injection were noted between the two groups. Individual t tests showed significant pain differences between the two groups at the time after the injection and at 10- and 20-minute and 6-hour intervals. Repeated-measures analysis of variance models showed that the diluent effect on pain was significant.
CONCLUSION: Lidocaine can reduce the amount of pain of an intramuscular injection of ceftriaxone when compared with sterile water as a diluent. These findings have implications not only for the treatment of gonorrhea but also for other situations where intramuscular injections utilizing a diluent may be necessary.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143016     DOI: 10.1001/archpedi.1994.02170010074017

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  3 in total

1.  Can Lidocaine be Safely Used to Reduce Pain Caused by Intramuscular Penicillin Injections? A Short Literature Review.

Authors:  Amir Emami Zeydi; Hadi Darvishi Khezri
Journal:  Oman Med J       Date:  2012-07

Review 2.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes.

Authors:  Sara Houlihan; Diane Decarie; Cindy Benes; Richard Cleve; Marianne Vidler; Laura A Magee; Mary H H Ensom; Peter von Dadelszen
Journal:  J Obstet Gynaecol Can       Date:  2016-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.